• Okadaic acid (A4540): Protocols for PP1/PP2A Inhibition

  2026-05-27

  Okadaic acid is a nanomolar-range protein phosphatase 1 inhibitor designed for robust, targeted suppression of PP1 and PP2A in cellular and biochemical assays. It is best employed in workflows requiring precise control of phosphorylation-dependent signaling, such as apoptosis and signal transduction studies. Its use should be avoided in applications where non-specific phosphatase inhibition or solvent composition may confound results.

• IEM 1460: AMPA Receptor Blocker for Advanced Neuroprotection

  2026-05-27

  IEM 1460 empowers neuroscience researchers with reproducible, selective AMPA receptor inhibition for dissecting excitotoxicity, synaptic transmission, and neuroprotection. This article translates cutting-edge findings into practical protocols, workflow optimizations, and troubleshooting strategies, making IEM 1460 an essential tool for translational neurobiology.

• P2RX1-Induced Mitochondrial Apoptosis in Ph+ ALL: Mechanisti

  2026-05-26

  Li et al. (2025) reveal that P2RX1 overexpression increases mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by disrupting calcium signaling and suppressing PI3K/Akt pathway activity. These findings clarify the mechanistic role of purinergic signaling in leukemia cell death and highlight P2RX1 as a potential therapeutic target for overcoming TKI resistance.

• EZ Cap™ Firefly Luciferase mRNA: Precision Reporter for mRNA

  2026-05-26

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure redefines reporter gene workflows by combining enhanced translation, robust stability, and minimal immunogenicity. This enables researchers to achieve highly sensitive mRNA delivery and translation efficiency assays, reliable in vivo bioluminescence imaging, and streamlined troubleshooting for both in vitro and preclinical studies.

• Clathrin-Mediated Entry of Grass Carp Reovirus: PI3K Inhibit

  2026-05-25

  Wang et al. (2018) provide a mechanistic dissection of type III grass carp reovirus (GCRV104) entry into host cells, demonstrating that clathrin-mediated endocytosis and PI3K activity are essential for infection. Their inhibitor analysis, including the use of Wortmannin, reveals actionable targets for virology and host-pathogen research.

• (R,S)-Anatabine for Alzheimer's: Protocols, Use-Cases, and T

  2026-05-25

  (R,S)-Anatabine offers a targeted approach to amyloid-beta reduction and inflammation modulation for advanced Alzheimer's disease research. This article delivers practical, evidence-based workflows, protocol enhancements, and troubleshooting strategies to maximize experimental success with this versatile neurodegeneration research compound.

• LY-411575: Gamma-Secretase Inhibitor for Advanced Disease Mo

  2026-05-24

  LY-411575 empowers researchers with nanomolar precision for dissecting amyloid beta production and Notch signaling in both neurodegeneration and cancer research. Its robust performance and proven workflow reliability unlock new avenues in disease modeling and immunotherapy strategies.

• Chrysin Potentiates Sunitinib Sensitivity by Inducing Ferrop

  2026-05-23

  This study demonstrates that chrysin, a natural flavonoid, significantly enhances the anti-tumor efficacy of sunitinib in renal cell carcinoma (RCC) by inducing ferroptosis via the PI3K/Akt/GPX4 pathway. These findings suggest a promising combination strategy to overcome sunitinib resistance in RCC models.

• Applied Use of PPT (Propyl Pyrazole Triol) in Estrogen Recep

  2026-05-22

  PPT (Propyl Pyrazole Triol) empowers researchers to dissect estrogen receptor alpha signaling with unmatched selectivity, streamlining workflows in cancer biology, developmental models, and gene expression studies. This article translates cutting-edge reference findings into practical protocols, comparative advantages, and troubleshooting strategies for maximizing the impact of APExBIO’s gold-standard reagent.

• Virus-Mimicking Particles Advance Extrahepatic mRNA Delivery

  2026-05-22

  This study introduces a self-assembling enveloped virus-mimicking particle (EVMP) platform that achieves efficient, targeted mRNA delivery to extrahepatic tissues such as lung and spleen. By modularly optimizing peptide and lipid components, the authors overcome hepatic tropism, demonstrating significant anti-tumor efficacy with IL-12 mRNA and establishing a versatile strategy for next-generation mRNA therapeutics.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-05-21

  Satir et al. (2020) demonstrate that partial inhibition of BACE1, the enzyme initiating amyloid-beta production, can significantly decrease amyloid-beta secretion without impairing synaptic transmission in cortical neurons. This finding supports the strategy of moderate BACE1 inhibition for Alzheimer's research, addressing safety concerns observed in previous clinical trials.

• Cationic Lipids Tune Immunogenicity in mRNA-LNP Vaccine Desi

  2026-05-21

  This study systematically investigates how cationic lipid incorporation into mRNA-lipid nanoparticle (LNP) vaccines modulates immunogenicity and efficacy. The findings reveal that classic cationic lipids can fine-tune immune activation and antitumor responses, offering practical strategies for optimizing mRNA-LNP vaccine formulations.

• Zosuquidar (LY335979) 3HCl: Data-Driven MDR Solutions for La

  2026-05-20

  This article guides biomedical researchers through real-world challenges in multidrug resistance (MDR) workflows, focusing on the reproducibility and sensitivity gains achieved with Zosuquidar (LY335979) 3HCl (SKU A3956). Integrating peer-reviewed evidence, practical scenarios, and vendor reliability analysis, it positions this P-gp inhibitor as an optimal choice for robust cytotoxicity and drug sensitization experiments.

• Optimizing Apoptosis Detection with Annexin V-Cy5/DAPI Kit (

  2026-05-20

  This article addresses real-world laboratory challenges in apoptosis and necrosis analysis, demonstrating how the Annexin V-Cy5/DAPI Apoptosis Kit (SKU K2255) delivers rapid, reproducible, and quantitative results for cell viability and cytotoxicity assays. Researchers will gain scenario-driven guidance on protocol optimization, data interpretation, and product selection, grounded in peer-reviewed evidence and best practices.

• Amyloid Beta-peptide (25-35): Precision in Neurotoxicity Mod

  2026-05-19

  Amyloid Beta-peptide (25-35) (human) is the gold-standard fragment for modeling Alzheimer's neurotoxicity and microglial polarization. This article delivers advanced workflow insights, troubleshooting strategies, and translational context—empowering researchers to harness the full reproducibility and mechanistic clarity of APExBIO's Aβ25-35 in neurodegenerative disease research.

16196 records 1/1080 page Next 12345 下5页 Last page